Doug Fambrough News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Doug fambrough. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Doug Fambrough Today - Breaking & Trending Today

Anjarium Biosciences Appoints Gaurav Shah as Chairperson and Douglas Fambrough as Non-executive Director

Board expansion brings significant additional gene therapy and corporate development expertise to AnjariumZURICH, Oct. 18, 2022 /PRNewswire/ Anjarium Biosciences AG ("Anjarium"), a biotech ....

United States , Eleanor Perkin , Douglas Fambrough , Gaurav Shah , George Underwood , Stephen Yoo , Anjarium Biosciences , Eli Lilly , Sloan Kettering , Bali Muralidhar , Prnewswire Anjarium Biosciences , Kostenloser Wertpapierhandel , Bram Vanparys , Dina Chaya Moghrabi , Doug Fambrough , University Of California , Rocket Pharmaceuticals , Cornell University , Columbia University , Harvard University , Dicerna Pharmaceuticals , Novo Nordisk , Global Program Head , Chief Executive Officer , Non Executive Director , Rocket Pharma ,

hepatitis B

hepatitis B
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

France General , Douglas Fambrough , Gregory Renza , Madhu Kumar , Johnson Johnsonfriday , Codiak Biosciences , Gbola Amusa , Doug Fambrough , Douglasm Fambrough , Brian Abrahams , Gilead Sciences Inc , Advisory Committee On Immunization , Pharmathene Inc , Solar Power Company Array Technologies , Assembly Biosciences Hepb Antiviral Data , International Liver Congress , Centers For Disease , Enochian Biosciences Inc , Arbutus Biopharma Corporation , Assembly Biosciences Inc , Arrowhead Pharmaceuticals Inc , Dynavax Technologies Corporation , Dicerna Pharmaceuticals Inc , Arbutus Biopharma Corp , Health Care , For Hepatitisb Programmonday ,

Dicerna Pharmaceuticals Inc (DRNA) Q1 2021 Earnings Call Transcript

Operator
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request.
I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead.
Lauren Stival
Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com. ....

United States , Robyn Karnauskas , Ed Arce , Doug Pagan , Henry Kranzler , Douglasw Pagan , Stephen Willey , Stephen Willey Stifel , Sheeram Aradhye , Mayank Mamtani , Smith Cowen , Rob Williams Goldman Sachs , Dicerna Gal , Rob Ciappenelli , Jim Weissman , Douglasm Fambrough , Yigal Nochomovitz , Robertd Ciappenelli , Yigal Nochomovitz Citigroup , Jonathan Miller Evercore , Shreeram Aradhye , Yaron Werber , Madhu Kumar , Bob Brown , Mani Foroohar , Jonathan Miller ,

Dicerna Pharmaceuticals Inc (DRNA) Q4 2020 Earnings Call Transcript

Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Dicerna Pharmaceuticals Full year 2020 Earnings Conference Call. As a reminder, this conference is being recorded at the company s request. I will now turn the call over to your host, Ms. Lauren Stival, Senior Director of Investor Relations at Dicerna. Please go ahead.
Lauren Stival
Senior Director of Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s full year 2020 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results, we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com. You may also listen to this conference call via webcast on our website, which will be archived beginning approximately two hours after the call is completed. Speaking on today s call will be Dicerna s President and ....

United States , Shreeram Aradhye , Doug Pagan , Bob Brown , Dicerna Gal , Doug Fambrough , Douglasm Fambrough , Jim Weissman , Rob Ciappenelli , University Of Pennsylvania Perelman School Medicine , Dicerna Pharmaceuticals , Novo Nordisk , Dicerna Pharmaceuticals Inc , Dicerna Pharmaceuticals Full , Lauren Stival , Senior Director , Investor Relations , Chief Medical Officer , Chief Financial Officer , Chief Operating Officer , Chief Commercial Officer , Chief Scientific Officer , Risk Factors , Chief Executive , Vice President , Chief Medical ,

Primary Hyperoxaluria

Ever heard of RNA Interference?
In case you haven’t, Benzinga reached out to Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)’s CEO Douglas M. Fambrough, Ph.D., and asked him to explain how it works.
Silencing Genes
“RNA Interference (RNAI) is a natural process. It is a biological. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to: ....

Douglas Fambrough , Douglasm Fambrough , Doug Fambrough , Dicerna Pharmaceuticals Inc , Primary Hyperoxaluria , Pharmaceuticals Inc , Goals For , Competitors And Prospects Under Trumpwednesday , Financials And Institutional Investorsthursday , Partnerships And Stock Performancewednesday , Used To Treat Rare Genetic Diseasestuesday , டக்ளஸ் பம்பிரௌக் , டக் பம்பிரௌக் , ப்ரைமரீ ஹைபராக்ஸலூரியா , மருந்துகள் இன்க் , இலக்குகள் க்கு ,